Bay City Capital Fund IV, L.P.'s Net Worth

$0

Estimate Recalculated Nov 11, 2024 02:49AM EST

Who is Bay City Capital Fund IV, L.P.?

Bay City Capital Fund IV, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EnteroMedics Inc, MAP Pharmaceuticals, Inc., SYNTA PHARMACEUTICALS CORP, NEVRO CORP, NEORX CORP, and CORAUTUS GENETICS INC.

SEC CIK

Bay City Capital Fund IV, L.P.'s CIK is 0001360243

Past Insider Trading and Trends

2007 was Bay City Capital Fund IV, L.P.'s most active year for disposing of shares, totalling 3 transactions. Bay City Capital Fund IV, L.P.'s most active month to dispose stocks was the month of September. In 2007 Bay City Capital Fund IV, L.P. cashed out on 2,170,607 shares for a total of $31,478,142.72, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EnteroMedics Inc No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.67%
840K
$1.65
$1,386,000.00
4.9M
Sep 23
Form 4
+104.70%
3.33M
$1.74
$2,958,000.00
6.5M
Dec 14
Form 4
—
0
—
—
0
Sep 30
Form 4
+59.31%
1.65M
$1.15
$1,896,907.75
4.43M
Feb 19
Form 4
+1.82%
49.6K
$1.10
$54,560.00
2.78M
Oct 24
Form 4
+0.92%
25K
$4.50
$112,500.00
2.73M
Apr 29
Form 4
+1.88%
50K
$4.50
$225,000.00
2.71M
Apr 24
Form 4
+0.80%
21K
$8.66
$181,860.00
2.66M
Feb 29
Form 4
+602.80%
2.26M
—
—
2.64M
Nov 20
Form 4
∞
375K
$8.00
$3,000,000.00
375K
Nov 15
Form 3
—
0
—
—
0
No matching records found

SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-35.28%
-824.17K
—
—
1.51M
Dec 3
Form 4
-1.85%
-43.54K
—
—
2.31M
Dec 1
Form 4
-39.63%
-1.55M
—
—
2.35M
Sep 4
Form 4
-41.17%
-30.00K
$109.74
-$3,292,195.83
42.88K
Aug 17 - Aug 19
Form 4
-9.60%
-412.24K
—
—
3.88M
May 27
Form 4
-22.31%
-1.20M
$105.47
-$126,564,000.00
4.18M
Dec 13
Form 3
—
0
—
—
0
No matching records found

NEVRO CORP (NVRO) Snapshot price: $5.09

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.18%
-491.83K
$47.94
-$23,578,569.90
1.73M
Jun 8
Form 4
+9,154.97%
2.19M
—
—
2.22M
Nov 12
Form 3
—
0
—
—
0
No matching records found

NEORX CORP No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.44%
74.97K
$5.80
$442,223.16
16.93M
Aug 30
Form 4
+0.09%
4.94K
$5.75
$28,381.15
5.57M
Aug 29
Form 4
+0.05%
5.17K
$5.49
$28,338.72
11.12M
Aug 14 - Aug 16
Form 4
+0.25%
13.63K
$5.50
$74,976.00
5.56M
Aug 10
Form 4
+23.18%
1.04M
$6.33
$6,605,456.28
5.55M
Apr 30
Form 3
—
0
—
—
0
No matching records found

CORAUTUS GENETICS INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Mar 26
Form 4
—
0
—
—
0
Mar 12
Form 4
+48.44%
4.07M
$2.43
$9,880,336.26
12.46M
Aug 8
Form 4
∞
8.39M
—
—
8.39M
Jun 5
Form 3
—
0
—
—
0
No matching records found